Barchart on Facebook
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Inmed Pharmaceuticals IN (IN.TO)

Inmed Pharmaceuticals IN (IN.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 24,851
  • Shares Outstanding, K 5,221
  • Annual Sales, $ 0 K
  • Annual Income, $ -11,857 K
  • 60-Month Beta 2.49
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 3.26
Trade IN.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -2.27
  • Most Recent Earnings -0.29 on 06/30/20
  • Next Earnings Date 11/13/20
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

    TSX Biotechnology

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.66
  • Growth Rate Est. (year over year) +151,463.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.00 +19.50%
on 10/08/20
5.00 -4.40%
on 10/14/20
-0.10 (-2.05%)
since 09/18/20
3-Month
4.00 +19.50%
on 10/08/20
7.78 -38.56%
on 08/07/20
-2.13 (-30.82%)
since 07/20/20
52-Week
4.00 +19.50%
on 10/08/20
14.19 -66.31%
on 01/21/20
-4.13 (-46.35%)
since 10/18/19

Most Recent Stories

More News
InMed Announces Completion of Subject Treatments in Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects

, /PRNewswire/ - ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way...

IN.TO : 4.78 (+0.42%)
IMLFF : 3.6200 (+0.28%)
InMed Pharmaceuticals Announces Additional IntegraSyn™ Patent Filing

, /PRNewswire/ -  ("InMed" or the "Company") (TSX:IN) (OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way...

IN.TO : 4.78 (+0.42%)
IMLFF : 3.6200 (+0.28%)
InMed Pharmaceuticals Announces Additional IntegraSyn™ Patent Filing

TSX:IN OTCQX:IMLFF

IN.TO : 4.78 (+0.42%)
IMLFF : 3.6200 (+0.28%)
Stocks in play: InMed Pharmaceuticals Inc.

Today reported financial results for the fiscal year ended June 30, 2020. The Company recorded a net ...

IN.TO : 4.78 (+0.42%)
InMed Pharmaceuticals Reports Full Year Fiscal 2020 Financial Results and Provides Business Update

VANCOUVER, BC , Sept. 8, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical company developing medications targeting...

IMLFF : 3.6200 (+0.28%)
IN.TO : 4.78 (+0.42%)
InMed Pharmaceuticals to Report Full Year Fiscal 2020 Financial Results and Business Update on September 8, 2020

  , /PRNewswire/ -  ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a clinical stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading...

IN.TO : 4.78 (+0.42%)
IMLFF : 3.6200 (+0.28%)
InMed Pharmaceuticals to Report Full Year Fiscal 2020 Financial Results and Business Update on September 8, 2020

TSX:IN OTCQX:IMLFF  

IN.TO : 4.78 (+0.42%)
IMLFF : 3.6200 (+0.28%)
InMed Introduces IntegraSyn™: An Integrated Cannabinoid Manufacturing System

, /PRNewswire/ - ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the way...

IN.TO : 4.78 (+0.42%)
IMLFF : 3.6200 (+0.28%)
InMed Introduces IntegraSyn™: An Integrated Cannabinoid Manufacturing System

VANCOUVER, BC , June 24, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications targeting...

IMLFF : 3.6200 (+0.28%)
IN.TO : 4.78 (+0.42%)
InMed Announces Filing of Registration Statement in Connection with United States Offering, Application to Seek Nasdaq Listing and Planned Share Consolidation

, /PRNewswire/ -  ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the...

IN.TO : 4.78 (+0.42%)
IMLFF : 3.6200 (+0.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

2nd Resistance Point 5.03
1st Resistance Point 4.89
Last Price 4.78
1st Support Level 4.56
2nd Support Level 4.37

See More

52-Week High 14.19
Fibonacci 61.8% 10.30
Fibonacci 50% 9.10
Fibonacci 38.2% 7.89
Last Price 4.78
52-Week Low 4.00

See More

Business Summary

InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of...

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar